Cell and Gene Therapies

TIA brings together five leading cell and gene therapy development

and manufacturing facilities in Australia to facilitate the translation

from discovery to clinical benefit, ensuring that manufacturing occurs

in compliance with regulations and that products entering clinical

trials are of a sufficiently high standard.

TIA has partnered with CCRM Australia, an organisation that accelerates the commercialisation of Australian regenerative medicine therapies and related technologies. CCRM achieves this through engagement and fostering local and international collaboration between industry, clinicians and academia.

Capabilities/Services offered  >

Cell and Tissue Therapies WA 


Q-Gen Cell Therapeutics 

Capabilities/Services offered  >
Capabilities/Services offered  >

Cell & Molecular Therapies, RPA Hospital

RPAH crest.JPG
Capabilities/Services offered  >

Sydney Cell and Gene Therapy 

Capabilities/Services offered  >

Centre of Excellence in Cellular Immunotherapy


Level 14, 330 Collins St

Melbourne 3000 VIC


T: +61 (07) 3735 4433

©2019 Therapeutic Innovation Australia


Enabled by